2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow arm 3: new trials by email Literature Review of arm 3 trials Research Report on arm 3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2 Valacyclovir celecoxib dose 1, Valacyclovir celecoxib dose 2, Placebo - Long COVID, PASC Post Acute Sequelae of COVID 19 | Phase 2 | Completed | Bateman Horne Center | 59 | 2023-10-15 | 2025-01-22 |
| Study of of URC102 to Assess the Efficacy and Safety in Gout Patients arm 0, arm 1, arm 2 - Gout | Phase 2 | Completed | JW Pharmaceutical | 171 | 2019-01-21 | 2021-03-18 |
Gout (1) · Post-Acute COVID-19 Syndrome (1)
Bateman Horne Center (1) · JW Pharmaceutical (1)
South Korea (1) · United States (1)